(19)
(11) EP 1 137 774 A2

(12)

(88) Date of publication A3:
09.11.2000

(43) Date of publication:
04.10.2001 Bulletin 2001/40

(21) Application number: 99967225.6

(22) Date of filing: 08.12.1999
(51) International Patent Classification (IPC)7C12N 15/12, C07K 14/475, C07K 16/22, C12N 5/10, C12N 5/12, A61K 38/18, A61K 35/12
(86) International application number:
PCT/US9928/975
(87) International publication number:
WO 0034/475 (15.06.2000 Gazette 2000/24)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 09.12.1998 US 111626 P

(71) Applicant: Amgen Inc.
Thousand Oaks, CA 91320-1799 (US)

(72) Inventors:
  • SIMONET, William, Scott
    Thousand Oaks, CA 91360 (US)
  • ASUNCION, Franklin, J.
    Simi Valley, CA 93065 (US)
  • MIN, Hosung
    Sherman Oaks, CA 91401 (US)
  • JING, Shuqian
    Thousand Oaks, CA 91362 (US)

(74) Representative: Richardson, Kate et al
Forrester & Boehmert,Pettenkoferstrasse 20-22
80336 München
80336 München (DE)

   


(54) GRNF4, A GDNF-RELATED NEUROTROPHIC FACTOR